OPEN END TURBO BULL OPTIONSSCHEIN - IPSEN | Delayed Deutsche Boerse AG 10:44:58 2024-05-22 EDT | ||
| 3.27 EUR | +2.19% |
|
| Current month | +25.49% | ||
| 1 month | +60.80% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 24-05-22 | 3.27 | +2.19% |
| 24-05-21 | 3.2 | 0.00% |
| 24-05-20 | 3.2 | +1.91% |
| 24-05-17 | 3.14 | -2.18% |
| 24-05-16 | 3.21 | +0.94% |
Delayed Quote Deutsche Boerse AG
Last update May 22, 2024 at 10:44 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
UniCredit
|
| WKN | HC2MMJ |
| ISIN | DE000HC2MMJ5 |
| Date issued | 2022-12-16 |
| Strike | 89.91 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.95 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.63 € |
|---|---|
| Lowest since issue | 1.37 € |
| Spread | 0.17 € |
| Spread % | 4.94% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
121.3
EUR
Average target price
126.3
EUR
Spread / Average Target
+4.15%
- Stock Market
- Certificates
- Certificat
